Indicative features of tissue and microbial sensitization in the pathogenesis of generalized parodontitis associated with rheumatoid arthritis

Authors

DOI:

https://doi.org/10.26641/2307-0404.2024.2.307620

Keywords:

rheumatoid arthritis, generalized periodontitis, reaction of inhibition of migrating leukocytes, tissue allergy, streptococcus antigen, staphylococcus antigen, synovial antigen

Abstract

In the literature, there are not enough studies that reflect the role and place of tissue and microbial sensitization in patients with generalized parodontitis (GP) associated with rheumatoid arthritis (RA). In our opinion, the research of these components will help to better understand the etiopathogenetic mechanisms of development of GP against the background of RA, which will improve the formation of preventive and therapeutic measures for this disease treatment. The purpose of the research was to determine the location and integration features of tissue and microbial sensitization in the pathogenesis of generalized parodontitis associated  with rheumatoid arthritis. Immunological studies were carried out in 335 people, who were divided into 4 groups: Group 1 – the main – consisted of 136 patients with GP on the background of RA; Group 2 – control – 71 people with GP without signs of RA; Group 3 – comparison – 128 people without GP, but with diseases of the musculoskeletal system not related to RA and Group 4 – 30 practically healthy people. To determine microbial and tissue sensitization, we used inhibition reaction of migrating lymphocytes with microbial antigens of streptococci and staphylococci, tissue antigens (bone and synovial). A high frequency of microbial sensitization to streptococcal and staphylococcal antigens was established in patients with GP on the background of RA and in patients with GP without signs of RA. The parodontal focus turned out to be an active focus of microbial sensitization in patients with GP associated  with RA and in patients with GP without signs of RA. Established sensitization to bone antigen in a small number of patients (27-33%) with GP, which was significantly more frequent (61-80%) in patients with GP associated  with RA, indicates that in the latter, allergy is to a greater extent due to tissue systemic damage to connective tissue than GP. However, a certain allergy to bone tissue in GP may indicate the inclusion of an immune component in the pathogenesis of GP. The presence of microbial and tissue sensitization in patients with GP and RA indicates that similar and cross antigens of streptococcal and staphylococcal microorganisms with connective tissue are a potential trigger for the development of both GP and RA, which is a reason to consider GP and RA comorbid diseases with similar pathogenetic mechanisms of development.

References

Kaku M, Matsuda S, Kubo T, Shimoe S, Tsuga K, Kurihara H, et al. Generalized periodontitis treated with periodontal, orthodontic, and prosthodontic therapy: A case report. World J Clin Cases. 2021 Jul 26;9(21):6110-24. doi: https://doi.org/10.12998/wjcc.v9.i21.6110

Kopchak OV, Marchenko NS, Yanishevska YV. Modeling of chronic generalized periodontitis in laboratory animals (literature review). Medicni perspektivi. 2020;25(3):22-9. doi: https://doi.org/10.26641/2307-0404.2020.3.214646

Simons G, Caplan J, DiSantostefano RL, Veldwijk J, Englbrecht M, Bywall KS, et al. Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk popu-lations. Arthritis Res Ther. 2022 Feb 22;24(1):55. doi: https://doi.org/10.1186/s13075-021-02707-4

Díaz-Torné C, Urruticoechea-Arana A, Ivorra-Cortés J, Díaz S, Dilla T, Sacristán JA, et al. What Matters Most to Patients and Rheumatologists? A Discrete Choice Experiment in Rheumatoid Arthritis. Adv Ther. 2020 Apr;37(4):1479-95. doi: https://doi.org/10.1007/s12325-020-01258-5

Nikiphorou E, de Lusignan S, Mallen CD, Kha-vandi K, Bedarida G, Buckley CD, et al. Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study. Heart. 2020 Oct;106(20):1566-72. doi: https://doi.org/10.1136/heartjnl-2019-316193

Kanbori M, Suzuka H, Yajima T, Kishino E, Mo-rishige R, Momohara S, et al. Postmarketing surveillance evaluating the safety and effectiveness of golimumab in Japanese patients with rheumatoid arthritis. Mod Rheumatol. 2018 Jan;28(1):66-75. doi: https://doi.org/10.1080/14397595.2017.1325058

Okazaki M, Kobayashi H, Shimizu H, Ishii Y, Yajima T, Kanbori M. Safety, Effectiveness, and Treat-ment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan. Rheumatol Ther. 2018 Jun;5(1):135-48. doi: https://doi.org/10.1007/s40744-018-0101-y

Antonenko M, Reshetnyk L, Zelinskaya N, Stolyar V, Revych V. Diversity of treatment of generalized periodontal diseases in patients with anorexia nervosa. Georgian Med News. 2020 Sep;(306):46-51. PMID: 33130645.

Bywall KS, Kihlbom U, Hansson M, Falahee M, Raza K, Baecklund E, et al. Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients. Arthritis Res Ther. 2020 Dec 19;22(1):288. doi: https://doi.org/10.1186/s13075-020-02391-w

Falahee M, Finckh A, Raza K, Harrison M. Preferences of Patients and At-risk Individuals for Preventive Approaches to Rheumatoid Arthritis. Clin Ther. 2019 Jul;41(7):1346-54. doi: https://doi.org/10.1016/j.clinthera.2019.04.015

Mankia K, Siddle HJ, Kerschbaumer A, Alpizar Rodriguez D, Catrina AI, Cañete JD, et al. EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis. Ann Rheum Dis. 2021 Oct;80(10):1286-98. doi: https://doi.org/10.1136/annrheumdis-2021-220884

Mankia K, Cheng Z, Do T, Hunt L, Meade J, Kang J, et al. Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without Arthritis. JAMA Netw Open. 2019 Jun 5;2(6):e195394. doi: https://doi.org/10.1001/jamanetworkopen.2019.5394

Rodríguez-Lozano B, González-Febles J, Garnier-Rodríguez JL, Dadlani S, Bustabad-Reyes S, Sanz M, et al. Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: a case-control study. Arthritis Res Ther. 2019 Jan 18;21(1):27. doi: https://doi.org/10.1186/s13075-019-1808-z

Kobayashi T, Bartold PM. Periodontitis and perio¬dontopathic bacteria as risk factors for rheumatoid arthritis: A review of the last 10 years. Jpn Dent Sci Rev. 2023 Dec;59:263-72. doi: https://doi.org/10.1016/j.jdsr.2023.08.002

Hascoët E, Blanchard F, Blin-Wakkach C, Guicheux J, Lesclous P, Cloitre A. New insights into inflam-matory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis. Bone Res. 2023 May 22;11(1):26. doi: https://doi.org/10.1038/s41413-023-00257-w

Corrêa JD, Fernandes GR, Calderaro DC, Mendonça SMS, Silva JM, Albiero ML, et al. Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients. Sci Rep. 2019 Jun 10;9(1):8379. doi: https://doi.org/10.1038/s41598-019-44674-6

Möller B, Kollert F, Sculean A, Villiger PM. Infectious Triggers in Periodontitis and the Gut in Rheumatoid Arthritis (RA): A Complex Story About Asso-ciation and Causality. Front Immunol. 2020 Jun 3;11:1108. doi: https://doi.org/10.3389/fimmu.2020.01108

Hruzieva TS, Lekhan VM, Ohniev VA, Haliienko LI, Kriachkova LV, Palamar BI, et al. [Biostatistics]. Vinnytsia: New Book; 2020. 384 p. Ukrainian.

Downloads

Published

2024-06-28

How to Cite

1.
Proschenko A, Proschenko N, Reshetnyk L, Zelinskaya N, Chervonna N, Melnychyk T. Indicative features of tissue and microbial sensitization in the pathogenesis of generalized parodontitis associated with rheumatoid arthritis. Med. perspekt. [Internet]. 2024Jun.28 [cited 2024Nov.20];29(2):168-74. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/307620

Issue

Section

CLINICAL MEDICINE